Lipid Screening for Cardiovascular Disease
Developments in lipid testing over recent years may signal a better alternative to taking cholesterol levels when it comes to evaluating patients at risk for cardiovascular events.
Read MorePosted by Jenny Lower | Feb 25, 2015 | Cardiovascular |
Developments in lipid testing over recent years may signal a better alternative to taking cholesterol levels when it comes to evaluating patients at risk for cardiovascular events.
Read MorePosted by Jenny Lower | Feb 4, 2015 | Cancer |
President Obama’s announcement of a new precision medicine initiative in his State of the Union address has significant implications for the clinical laboratory community.
Read MorePosted by Jenny Lower | Dec 31, 2014 | Kidney Disease, Uncategorized |
To determine how recommendations for chronic kidney disease testing in laboratory and point-of-care environments are shifting, CLP spoke to Robert H. Christenson, PhD, professor of pathology and medical and research technology at the University of Maryland School of Medicine and past president of the American Association for Clinical Chemistry.
Read MorePosted by Steve Halasey | Nov 18, 2014 | Research |
A diagnostic technology from NanoSomiX may be useful in measuring prognosis and treatment of Alzheimer’s disease.
Read MorePosted by Steve Halasey | Nov 10, 2014 | Emerging & Zoonotic Diseases, Infectious Diseases |
US testing for chikungunya is unlikely to taper off during the fall and winter, as travelers returning from outbreak areas remain at risk.
Read More